A. Jacques

Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI

S. Withey, V. Goh, N. Griffin, 2021, European Journal of Hybrid Imaging.

Does a high Mandard score really de fi ne a poor response to chemotherapy in oesophageal adenocarcinoma?

S. Ngan, S. Zeki, J. Meenan, 2021 .

Effect of peri-operative chemotherapy regimen on survival in the treatment of locally advanced oesophago-gastric adenocarcinoma - A comparison of the FLOT and 'MAGIC' regimens.

D. Cunningham, W. Allum, S Kumar, 2022, European journal of cancer.

MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib.

J. Christensen, K. Famulski, M. Aghi, 2010, Neuro-oncology.

Does a high Mandard score really define a poor response to chemotherapy in oesophageal adenocarcinoma?

J. Gossage, A. Davies, H. Deere, 2021, British Journal of Cancer.

Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population

V. Goh, N. Griffin, J. Lagergren, 2022, Annals of Surgical Oncology.

Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma

N. Griffin, J. Lagergren, J. Gossage, 2023, European Radiology.

Association of dynamic contrast-enhanced MRI and 18F-Fluorodeoxyglucose PET/CT parameters with neoadjuvant therapy response and survival in esophagogastric cancer.

S. Withey, V. Goh, A. Davies, 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.